0000879169 false 0000879169 2021-05-26 2021-05-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 26, 2021

 

INCYTE CORPORATION 

(Exact name of registrant as specified in its charter)

 

Delaware
(State or Other Jurisdiction of
Incorporation)		   001-12400
(Commission File Number)		   94-3136539
(I.R.S. Employer
Identification No.)

 

1801 Augustine Cut-Off    
Wilmington, DE   19803
(Address of principal executive offices)   (Zip Code)

 

(302) 498-6700

(Registrant’s telephone number,
including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

¨      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)    Name of each exchange on which registered
Common Stock, $.001 par value per share   INCY   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).

 

Emerging growth company   ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

2010 Amended and Restated Stock Incentive Plan Amendments

 

At the Annual Meeting of Stockholders of Incyte Corporation (the “Company”) held on May 26, 2021 (the “Annual Meeting”), the stockholders of the Company approved the following amendments to the Company’s Amended and Restated 2010 Stock Incentive Plan (the “Plan”): (a) an increase in the number of shares available for issuance under the Plan by 9,500,000 shares, from 44,453,475 shares to 53,953,475 shares, (b) extend the termination date of the Plan from June 30, 2021 to June 30, 2026 and (c) change the automatic grants of equity awards to outside (non-employee and non-consultant) directors to provide that such directors will receive annual grants with an aggregate grant date fair value to be determined at the discretion of the Company’s board of directors, provided that such value does not exceed $500,000, and to change the mix of such annual grants from 75% stock options and 25% restricted stock units to 60% stock options and 40% restricted stock units. A copy of the Plan, as amended and restated on May 13, 2021 and including the amendments approved by the stockholders, is attached hereto as Exhibit 10.1 and incorporated herein by reference.

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The following actions were taken at the Annual Meeting:

 

1.The following Directors were elected:

 

   For   Against   Abstain   Broker Non-
Votes		 
Julian C. Baker   177,365,394    12,500,019    41,822    10,876,335 
Jean-Jacques Bienaimé   183,659,510    6,170,541    77,184    10,876,335 
Paul J. Clancy   186,012,358    3,820,486    74,391    10,876,335 
Wendy L. Dixon   186,745,011    3,082,584    79,640    10,876,335 
Jacqualyn A. Fouse   187,616,292    2,210,665    80,278    10,876,335 
Edmund P. Harrigan   188,646,843    1,183,427    76,965    10,876,335 
Katherine A. High   188,356,062    1,471,490    79,683    10,876,335 
Hervé Hoppenot   179,673,534    8,848,103    1,385,598    10,876,335 

 

2.The compensation of the Company’s named executive officers was approved, on a non-binding advisory basis.

 

For   Against   Abstain   Broker Non-Votes 
175,778,841   14,039,038   89,356   10,876,335 

 

3.The amendments to the Company’s Amended and Restated 2010 Stock Incentive Plan were approved.

 

For   Against   Abstain   Broker Non-Votes 
168,346,598   21,469,876   90,761   10,876,335 

 

4.The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2021 fiscal year was ratified.

 

For   Against   Abstain 
195,782,434   4,883,155   117,981 

 

Item 9.01Financial Statements and Exhibits.

 

(d)            Exhibits

 

10.1Amended and Restated 2010 Stock Incentive Plan, as amended and restated on May 13, 2021.

104Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 26, 2021

 

  INCYTE CORPORATION
   
   
  By: /s/ Maria E. Pasquale
    Maria E. Pasquale
    Executive Vice President and
    General Counsel